Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10229096rdf:typepubmed:Citationlld:pubmed
pubmed-article:10229096lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0024348lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0439859lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:10229096lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:10229096pubmed:issue4lld:pubmed
pubmed-article:10229096pubmed:dateCreated1999-5-13lld:pubmed
pubmed-article:10229096pubmed:abstractTextWe studied HLA class I expression and susceptibility to lysis of activated autologous NK cells in normal and TAP-deficient fibroblasts. These cells were cultured in the presence or absence of cytokines known to increase the surface expression of HLA class I molecules. All the cytokines tested (IFN-alpha, IFN-gamma, TNF-alpha and IFN-gamma + TNF-alpha) increased the expression of HLA class I molecules on fibroblasts after 48-h culture, but on TAP-deficient cells this expression remained very low as compared to that of normal cells. In the presence of IFN-alpha, IFN-gamma or IFN-gamma + TNF-alpha, normal target cells became resistant to lysis by autologous NK cells, whereas this effect was much less pronounced in the case of TAP-deficient fibroblasts. Addition of an anti-HLA class I mAb to fibroblasts treated with cytokines increased lysis of normal but not of TAP-deficient cells. These results suggest that activated TAP-deficient NK cells are strongly cytotoxic to normal autologous cells and that these cells cannot be efficiently protected by cytokines inducing HLA class I expression. Thus, in human TAP deficiency, activated NK cells may contribute to the progressive lung degradation which characterizes the clinical course of these patients.lld:pubmed
pubmed-article:10229096pubmed:languageenglld:pubmed
pubmed-article:10229096pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:citationSubsetIMlld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229096pubmed:statusMEDLINElld:pubmed
pubmed-article:10229096pubmed:monthAprlld:pubmed
pubmed-article:10229096pubmed:issn0014-2980lld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:TongioM MMMlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:ZimmerJJlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:CazenaveJ PJPlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:MorettaAAlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:DonatoLLlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:HanasJJlld:pubmed
pubmed-article:10229096pubmed:authorpubmed-author:de la SalleHHlld:pubmed
pubmed-article:10229096pubmed:issnTypePrintlld:pubmed
pubmed-article:10229096pubmed:volume29lld:pubmed
pubmed-article:10229096pubmed:ownerNLMlld:pubmed
pubmed-article:10229096pubmed:authorsCompleteYlld:pubmed
pubmed-article:10229096pubmed:pagination1286-91lld:pubmed
pubmed-article:10229096pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:meshHeadingpubmed-meshheading:10229096...lld:pubmed
pubmed-article:10229096pubmed:year1999lld:pubmed
pubmed-article:10229096pubmed:articleTitleInefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.lld:pubmed
pubmed-article:10229096pubmed:affiliationCJF INSERM 94-03, Etablissement de Transfusion Sanguine, Strasbourg, France.lld:pubmed
pubmed-article:10229096pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10229096pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229096lld:pubmed